KETOCONAZOLE IN THE TREATMENT OF CHRONIC IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY

Abstract

Ketoconazole lowered endogenous cortisol after 4 weeks of 600 mg daily. While median visual acuity, lesion height, and greatest linear dimension remained unchanged during the month of drug treatment, there may have been a delayed therapeutic response seen at 8 weeks.